Breakthroughs in Cancer Detection

Colorectal cancer is the second leading cause of cancer-related deaths in the U.S., yet it’s highly treatable when caught early. Despite this, one in three eligible Americans skips the recommended screenings, often because traditional methods are unpleasant and inconvenient. Now, a groundbreaking FDA-approved blood test is changing the game. This non-invasive test provides a simple, quick, and effective way to screen for colorectal cancer, with results in just two weeks. It’s already covered under Medicare, making it accessible to millions. Join us as we hear from a patient whose life was saved by this innovative test and learn how Guardant Health’s Shield Blood Test is improving early detection and outcomes. Early detection can mean the difference between life and death-find out how this new approach is transforming cancer care.
HLTUTV GUAHEA 000001 1080P